TG THERAPEUTICS, INC. (TGTX) /
The debt of TG THERAPEUTICS, INC. over the past 10 years
Chart TG THERAPEUTICS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, TG THERAPEUTICS, INC. had liquid cash of $141.97M and total debt of $245.65M: net debt of $103.67M. It had more liquid cash than debt at 9 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2025 ($245.65M) and lowest at the end of fiscal 2018 ($0).
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $141.97M* | $245.65M | -$103.67M |
| 2024ended Dec 31, 2024 | $311M* | $244.43M | $66.57M |
| 2023ended Dec 31, 2023 | $217.51M* | $100.12M | $117.39M |
| 2022ended Dec 31, 2022 | $161.68M* | $71.14M | $90.54M |
| 2021ended Dec 31, 2021 | $314.76M* | $67.76M | $247M |
| 2020ended Dec 31, 2020 | $605.43M* | $29.89M | $575.53M |
| 2019ended Dec 31, 2019 | $140.44M* | $28.97M | $111.47M |
| 2018ended Dec 31, 2018 | $68.9M* | $0 | $68.9M |
| 2017ended Dec 31, 2017 | $84.72M* | $128K | $84.59M |
| 2016ended Dec 31, 2016 | $44.89M* | $68.88K | $44.82M |
Fiscal years as TG THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on TG THERAPEUTICS, INC.
- The revenue of TG THERAPEUTICS, INC.
- The profitability of TG THERAPEUTICS, INC.
- The cash flow of TG THERAPEUTICS, INC.
- All of TG THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- PRIPrimerica, Inc.
- VMIValmont Industries, Inc.
- SANMSanmina Corporation
- AOSA. O. Smith Corporation
- MORNMORNINGSTAR, INC.
Not investment advice. This page shows what TG THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.